FDA cites four more honey products for knockoff ED drugs

By Hank Schultz

- Last updated on GMT

©Getty Images - Jonathan Knowles
©Getty Images - Jonathan Knowles

Related tags Erectile dysfunction Dietary supplements Dietary supplement industry Food and drug administration

The US Food and Drug Administration has sent warning letters to four companies marketing sexual enhancement supplements ostensibly based on honey but which contained undeclared ED drugs. The warning letters were part of a ongoing enforcement effort on tainted sex products.

The four warning letters were made public last week.  They were sent to Thirstyrun LLC (also known as US Royal Honey LLC), MKS Enterprise LLC, Shopaax.com, 1am USA Incorporated dba Pleasure Products USA.

Honey as an aphrodisiac

The companies ostensibly were trading on the history of use of honey as an aphrodisiac.  Honey is one of the oldest foods harvested by humans, with depictions of honey gathering found in Spanish cave paintings dated to about 8,000 years ago.

The health properties associated with honey go back almost as far.  The complex combination of sugars and other constituents has noted antimicrobial properties.  It has been used in wound care for centuries.

The ingredient has also been purported to be an aphrodisiac. It has been associated with fertility since Biblical times, with quotations alluding to the ‘land of milk and honey.’

Unlike some of honey’s other health properties, these assertions find no backing in modern nutrition research, however.  According to the FDA warning letters, whatever sexual enhancement properties of the honey products might have is entirely due to the inclusion of undeclared pharmaceutical ingredients found in Cialis (tadalafil) and Viagra (sildenafil).

Dangers of hidden APIs with undeclared dosages

These ED drugs are contraindicated for men with high blood pressure, advanced cardiovascular disease and/or who are at a heightened risk of stroke.  According to FDA, the danger posed by these products is not only in the hidden nature of the APIs, but in the complete lack of dosing information.

“Tainted honey-based products like these are dangerous because consumers are likely unaware of the risks associated with the hidden prescription drug ingredients in these products and how they may interact with other drugs and supplements they may take,” ​said FDA Associate Commissioner for Regulatory Affairs Judy McMeekin, Pharm.D., “Products marketed with unidentified ingredients may be dangerous and, in some cases, deadly to consumers. We encourage consumers to remain vigilant when shopping online or in stores to avoid purchasing products that put their health at risk, and instead seek effective, FDA-approved treatments.”

In addition to the four warning letters made public last week, FDA updated a standing warning to consumers about other tainted products found​ in the market. That warning summed up the results of the most recent testing on an additional 15 products (beyond those mentioned the warning letters) done in 2022.  Of the 15 products tested in 2022, five had ‘honey’ in their names.

Related news

Show more

Related products

show more

Botanical extracts for various animal applications

Botanical extracts for various animal applications

Content provided by Verdure Sciences | 16-Jul-2024 | White Paper

In the pet health landscape, flexibility is crucial for formulators to cater to diverse pet needs. From mood & behavior to nutritional fortification,...

Deliver elevated gummy supplements with ADM

Deliver elevated gummy supplements with ADM

Content provided by ADM | 15-Jul-2024 | White Paper

We strive to differentiate you from competitors by blending precise ingredient formulas with innovative supplement solutions.

New Dietary Supplement Formulations: Why Use A CDMO

New Dietary Supplement Formulations: Why Use A CDMO

Content provided by Gemini Pharmaceuticals, Inc | 20-Jun-2024 | White Paper

Every Brand Owner wants to bring to market the “latest and greatest” dietary supplement under their label. Often, this “groundbreaking” idea or product...

The solutions to botanical supply chain challenges

The solutions to botanical supply chain challenges

Content provided by Ayana Bio | 05-Jun-2024 | Infographic

Many botanicals continue to face supply chain challenges, from the surging demand for stress-relieving adaptogens and immune-support ingredients to the...

Related suppliers

Follow us


View more